FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2549827521> ?p ?o ?g. }

• W2549827521 endingPage "19136" @default.
• W2549827521 startingPage "19125" @default.
• W2549827521 abstract "This study compared the short-term efficacies of different chemotherapy regimens in the treatment of advanced ovarian cancer (AOC) through pair-wise and network meta-analyses (NMA). Randomized controlled trials (RCTs) identified in a comprehensive online literature search met our inclusion criteria. Direct and indirect evidence was combined to compare odds ratios (OR) and surfaces under the cumulative ranking curves (SUCRA) across the different treatment regimens. Twelve eligible RCTs were finally included, involving eight regimens (Paclitaxel + Carboplatin [PC], Gemcitabine + Carboplatin [GC], Carboplatin, Pegylated Liposomal Doxorubicin + Carboplatin [PLD + Carboplatin], Paclitaxel, Paclitaxel + Carboplatin + Topotecan [PC + Topotecan], Paclitaxel + Carboplatin + Epirubicin [PC + Epirubicin] and Docetaxel + Carboplatin [DC]). The NMA results revealed that in terms of overall response rate (ORR) and disease control rate (DCR), PC (ORR: OR=2.59, 95%CI=1.20-6.22; DCR: OR=2.58, 95%CI=1.05-6.82) and GC (ORR: OR=2.08, 95%CI=1.08-4.37; DCR: OR=2.43, 95%CI=1.07-5.80) were more effective against AOC than Carboplatin alone. Similarly, PC (OR=0.21, 95%CI=0.05-0.69), GC (OR=0.31, 95%CI=0.09-0.90) and PLD + Carboplatin (OR=0.22, 95%CI=0.04-0.92) slowed disease progression better than Carboplatin alone. We also found that PC was more efficacious against AOC than Carboplatin or Paclitaxel single-agent chemotherapy. Combination chemotherapy is thus recommended for AOC, and should guide subsequent drug development and treatment strategies." @default.
• W2549827521 created "2016-11-30" @default.
• W2549827521 creator A5039308516 @default.
• W2549827521 creator A5056490700 @default.
• W2549827521 creator A5061363678 @default.
• W2549827521 creator A5075080019 @default.
• W2549827521 creator A5086908751 @default.
• W2549827521 creator A5090561112 @default.
• W2549827521 date "2016-11-09" @default.
• W2549827521 modified "2023-09-26" @default.
• W2549827521 title "A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer" @default.
• W2549827521 cites W1159765411 @default.
• W2549827521 cites W1515704543 @default.
• W2549827521 cites W1574056173 @default.
• W2549827521 cites W1650055942 @default.
• W2549827521 cites W1751946195 @default.
• W2549827521 cites W1966932597 @default.
• W2549827521 cites W1967385770 @default.
• W2549827521 cites W1976301747 @default.
• W2549827521 cites W1990163993 @default.
• W2549827521 cites W1992447918 @default.
• W2549827521 cites W1995033735 @default.
• W2549827521 cites W1996632091 @default.
• W2549827521 cites W2004474087 @default.
• W2549827521 cites W2010699829 @default.
• W2549827521 cites W2018863788 @default.
• W2549827521 cites W2027589610 @default.
• W2549827521 cites W2028240377 @default.
• W2549827521 cites W2036340596 @default.
• W2549827521 cites W2053629542 @default.
• W2549827521 cites W2055638608 @default.
• W2549827521 cites W2060522388 @default.
• W2549827521 cites W2068815946 @default.
• W2549827521 cites W2070404414 @default.
• W2549827521 cites W2088829688 @default.
• W2549827521 cites W2091145066 @default.
• W2549827521 cites W2091808438 @default.
• W2549827521 cites W2104505744 @default.
• W2549827521 cites W2105669432 @default.
• W2549827521 cites W2112644262 @default.
• W2549827521 cites W2115460467 @default.
• W2549827521 cites W2127143084 @default.
• W2549827521 cites W2129949847 @default.
• W2549827521 cites W2132972801 @default.
• W2549827521 cites W2135109254 @default.
• W2549827521 cites W2139799085 @default.
• W2549827521 cites W2142950083 @default.
• W2549827521 cites W2143219457 @default.
• W2549827521 cites W2143732277 @default.
• W2549827521 cites W2162318396 @default.
• W2549827521 cites W2163124976 @default.
• W2549827521 cites W2164909357 @default.
• W2549827521 cites W2168431214 @default.
• W2549827521 cites W2168951652 @default.
• W2549827521 cites W2202622618 @default.
• W2549827521 cites W2254581024 @default.
• W2549827521 cites W4236890023 @default.
• W2549827521 cites W4239651622 @default.
• W2549827521 cites W564298026 @default.
• W2549827521 doi "https://doi.org/10.18632/oncotarget.13253" @default.
• W2549827521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5386673" @default.
• W2549827521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27835912" @default.
• W2549827521 hasPublicationYear "2016" @default.
• W2549827521 type Work @default.
• W2549827521 sameAs 2549827521 @default.
• W2549827521 citedByCount "6" @default.
• W2549827521 countsByYear W25498275212017 @default.
• W2549827521 countsByYear W25498275212019 @default.
• W2549827521 countsByYear W25498275212021 @default.
• W2549827521 countsByYear W25498275212022 @default.
• W2549827521 crossrefType "journal-article" @default.
• W2549827521 hasAuthorship W2549827521A5039308516 @default.
• W2549827521 hasAuthorship W2549827521A5056490700 @default.
• W2549827521 hasAuthorship W2549827521A5061363678 @default.
• W2549827521 hasAuthorship W2549827521A5075080019 @default.
• W2549827521 hasAuthorship W2549827521A5086908751 @default.
• W2549827521 hasAuthorship W2549827521A5090561112 @default.
• W2549827521 hasBestOaLocation W25498275212 @default.
• W2549827521 hasConcept C121608353 @default.
• W2549827521 hasConcept C126322002 @default.
• W2549827521 hasConcept C143998085 @default.
• W2549827521 hasConcept C2776694085 @default.
• W2549827521 hasConcept C2776755627 @default.
• W2549827521 hasConcept C2777292972 @default.
• W2549827521 hasConcept C2777511904 @default.
• W2549827521 hasConcept C2778239845 @default.
• W2549827521 hasConcept C2780258809 @default.
• W2549827521 hasConcept C2780427987 @default.
• W2549827521 hasConcept C2780835546 @default.
• W2549827521 hasConcept C2781190966 @default.
• W2549827521 hasConcept C2781209748 @default.
• W2549827521 hasConcept C2781413609 @default.
• W2549827521 hasConcept C2781451048 @default.
• W2549827521 hasConcept C530470458 @default.
• W2549827521 hasConcept C71924100 @default.
• W2549827521 hasConcept C98274493 @default.
• W2549827521 hasConceptScore W2549827521C121608353 @default.
• W2549827521 hasConceptScore W2549827521C126322002 @default.

• next